Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

101647

registered interest
date	29/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will make an assessment of the potential merits of charging for NHS services required because of injuries caused by alcohol or drug misuse.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	212524
answer	answer is ministerial correction date of answer 05/11/2014 answer text <p>We recognise that drinking alcohol and drug use does place significant strain on the National Health Service, but there are both ethical and practical reasons not to seek payment from patients. The founding principle of the NHS is that services are free of charge, available to all on the basis of need, not ability to pay. It is funded accordingly, from general taxation.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 05/11/2014 15:40:41 answering member 3918 label Biography information for Jane Ellison
tabling member	4079 label Biography information for Julian Sturdy

101177

registered interest
date	27/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of legal highs upon public health.
tabling member constituency	Taunton Deane
tabling member printed	Mr Jeremy Browne
uin	212051
answer	answer is ministerial correction date of answer 04/11/2014 answer text <p>There have been a number of assessments of the health harms of new psychoactive substances (NPS) in recent years. These include the following:</p><p> </p><p> </p><p> </p><p>- a summary of the health harms of drugs published by the Department in August 2011 sets out an assessment of the health harms of novel psychoactive drugs among others. The report outlined acute and chronic problems associated these substances, but the date of the evidence review meant it was early to determine the actual harms of the NPS;</p><p> </p><p> </p><p> </p><p>- the Advisory Council on the Misuse of Drugs (ACMD) published its report ‘Consideration of the Novel Psychoactive Substances (‘Legal Highs’)’ in 2011. The report includes an assessment of the harms that these drugs cause;</p><p> </p><p> </p><p> </p><p> </p><p> </p><p>- since 2010, the ACMD has published a number of reports on their assessment of different types of NPS, including the harms they cause. The drugs the ACMD have reported on include tryptamines, NBOMe compounds, benzofurans, O-desmethyltramadol, methoxetamine, synthetic cannabinoids, and 2-DPMP (Ivory Wave);</p><p> </p><p> </p><p> </p><p>- on 30 October 2014, the Home Office published the report of an expert panel they appointed to look at the issue of NPS and provide recommendations to the Government. Alongside the report and the Government response, the Home Office also published an NPS evidence review. The evidence review found that that the available evidence suggests that the overall harms from NPS are low compared to the overall harms from traditional illicit drugs;</p><p> </p><p> </p><p> </p><p> </p><p> </p><p>- the Government’s Drugs Early Warning System (DEWS) helps ensure that harmful new substances are rapidly identified. Local and national intelligence gathered by DEWS – including health harms – assists the ACMD in its assessment of harms of NPS. On a broader scale, national intelligence is fed into a Europe-wide early warning system for new substances;</p><p> </p><p> </p><p> </p><p>- FRANK, the government’s drug information service, has information about the harms caused by NPS; and</p><p> </p><p> </p><p> </p><p>- Public Health England (PHE) is supporting and contributing clinical expertise to the first set of clinical guidelines on the acute management and treatment of novel psychoactive substances (NPS). Project NEPTUNE will advise clinicians on how to assess and respond to NPS related harm and is currently being developed by the Central and North West London NHS Foundation Trust. The guidelines are due to be published in 2015. PHE has committed to using its networks and other resources to support the dissemination of project NEPTUNE’s findings and advice.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 04/11/2014 16:09:45 answering member 3918 label Biography information for Jane Ellison
tabling member	1575 label Biography information for Mr Jeremy Browne

93584

registered interest
date	15/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether his Department is providing funding to the International Centre for Drug Policy to produce a National Programme on Substance Abuse Deaths to report for 2014.
tabling member constituency	Delyn
tabling member printed	Mr David Hanson
uin	210812
answer	answer is ministerial correction date of answer 20/10/2014 answer text <p>Public Health England officials are in discussions with St George's, University of London, concerning the production of a National Programme on Substance Abuse Deaths report covering the year 2013.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 20/10/2014 16:03:40 answering member 3918 label Biography information for Jane Ellison
tabling member	533 label Biography information for David Hanson

93585

registered interest
date	15/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether he plans to publish the number of deaths caused by volatile substance abuse in England and Wales in (a) 2013-14 and (b) future years.
tabling member constituency	Delyn
tabling member printed	Mr David Hanson
uin	210810
answer	answer is ministerial correction date of answer 20/10/2014 answer text <p>The Department has asked Public Health England to consider how future data on volatile substance abuse deaths might be collected and reported. Additionally, on 17 October 2014, the Office for National Statistics published a one-off report providing data on drug related deaths involving volatile substances and nitrous oxide in England and Wales, 1993–2013. A copy of the report is attached.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 20/10/2014 16:12:31 answering member 3918 label Biography information for Jane Ellison attachment 1 file name PQ210810 data.xlsx title Drug related deaths
tabling member	533 label Biography information for David Hanson

92012

registered interest
date	26/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate he has made of the cost to the NHS of the illegal use of controlled substances in (a) England, (b) Yorkshire and Humber, (c) South Yorkshire and (d) Barnsley East constituency.
tabling member constituency	Barnsley East
tabling member printed	Michael Dugher
uin	209391
answer	answer is ministerial correction date of answer 20/10/2014 answer text <p>The data is not available in the format requested. However, the Home Office published report ‘The Economic and Social Costs of Class A Drug Use in England and Wales’ estimated the cost of class A drug use to the National Health Service in England to be £488 million per year.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 20/10/2014 17:50:06 answering member 3918 label Biography information for Jane Ellison
tabling member	3916 label Biography information for Michael Dugher

62667

registered interest
date	18/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of the effectiveness of take-home naloxone in reducing the number of opiate-related deaths across the UK in conjunction with the training and educational programmes within the prison services.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	201224
answer	answer is ministerial correction date of answer 25/06/2014 answer text <p>From July 2009 to February 2010, the National Treatment Agency for Substance Misuse (now part of Public Health England (PHE)) ran a trial at 16 pilot sites around England in which carers and relations of opiate misusers were trained to respond to overdoses and use the antidote naloxone and basic life support techniques.</p><p> </p><p>A report[1] on the trial was published in 2011, and it was clear that naloxone appeared to help save lives. The report said that there were 18 overdoses where carers used naloxone and two where they applied basic life support. All the drug users survived the overdose. The trial included people who were about to leave prisons, and the report covers some of the issues around this.</p><p> </p><p>There is currently a trial running on the effectiveness of giving prisoners naloxone when they leave prison, which has yet to report.</p><p> </p><p>Some prisons currently supply prisons with take-home naloxone as part of their post-release support. PHE does not hold the data centrally.</p><p> </p><p>The Advisory Council on the Misuse of Drugs has recommended that naloxone be made more widely available, and the Medicines and Healthcare Products Regulatory Agency has undertaken a consultation with the field on implementing this recommendation. There will be no further policy announcements on naloxone until the report on this consultation is published.</p><br /><p>[1] Full report available at http://www.nta.nhs.uk/uploads/naloxonereport2011.pdf</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 25/06/2014 11:55:09 answering member 3918 label Biography information for Jane Ellison
tabling member	1604 label Biography information for Mr Virendra Sharma

62669

registered interest
date	18/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to reduce the incidence of opiate-related overdoses among people recently released from prison.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	201223
answer	answer is ministerial correction date of answer 25/06/2014 answer text <p>People who have recently been released from prison are at a greater risk of overdose. A 2005 report on drug-related mortality among newly released offenders (1998-2000) showed that male prisoners in the study were about 29 times more likely to die than males in the general population.</p><p> </p><p>The Department of Health and Ministry of Justice have funded a joint initiative to improve the “through the gate” provision for prisoners who are dependent on drugs and alcohol. Ten prisons in the North West are currently piloting a range of innovative interventions to provide more intensive support and supervision for people leaving custody which include the use of peer mentors, recovery housing services and take-home naloxone as they return to the community.</p><p> </p><p>Public Health England has also published a checklist to support local authorities with commissioning services and interventions that help to prevent overdose, as part of a wider treatment and harm reduction system.</p><p> </p><p>The Integrated Drug Treatment System (IDTS) programme, implemented in prisons between 2006 and 2010, sought to improve the standard and quality of drug treatment in prisons. One of the key drivers for this programme was the need to reduce drug-related deaths among people who had been recently released from prison.</p><p> </p><p>Through IDTS, prisoners could get access to evidence-based opioid substitution treatment in prison, which they could continue in the community after release. The extent in which this was successful in reducing drug-related overdose deaths will be one of the themes in the IDTS evaluation, which will be published next year.</p><p> </p><p>The principles of IDTS continue to be adopted by local partners responsible for commissioning health services.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 25/06/2014 11:52:07 answering member 3918 label Biography information for Jane Ellison
tabling member	1604 label Biography information for Mr Virendra Sharma